Atabaki-Pasdar, Naeimeh
Ohlsson, Mattias
Shungin, Dmitry
Kurbasic, Azra
Ingelsson, Erik
Pearson, Ewan R.
Ali, Ashfaq
Franks, Paul W.
Article History
Received: 13 July 2016
Accepted: 27 October 2016
First Online: 25 November 2016
Competing interests
: PWF has been a paid consultant for Eli Lilly and Sanofi Aventis. EP and PWF received research support from several pharmaceutical companies as part of a European Union Innovative Medicines Initiative (IMI) project. None of the remaining authors declare conflicts of interest relevant to this paper.